Isovue 300 Injection 61 %

ISOVUE 300 Injection 61% is a radiopaque contrast agent used for imaging procedures. This liquid formulation, manufactured by Bracco Imaging Canada, aids in enhancing visibility during diagnostic imaging.

ISOVUE 300 Injection 61% is primarily used as a contrast medium in medical imaging. It helps improve the visibility of internal structures during procedures like angiography, computed tomography (CT), and other diagnostic imaging techniques. This contrast agent is designed to be administered intravenously, making it suitable for various imaging needs.

When administered, ISOVUE 300 Injection 61% works by temporarily enhancing the contrast in the areas being imaged. This can help healthcare professionals obtain clearer images, which are crucial for accurate diagnosis and treatment planning. The effects are typically short-lived and localized to the areas being examined.

ISOVUE 300 Injection 61% should be handled with care and administered by trained healthcare professionals. It is important to follow proper procedures to ensure safety and effectiveness. Patients with known allergies to contrast agents should inform their healthcare provider before use.

ISOVUE 300 Injection 61% may interact with certain medications or medical conditions. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking. Always follow the advice of a healthcare professional regarding the use of this contrast agent.